• 치위생과학회지
• /
• 제23권4호
• /
• pp.369-377
• /
• 2023

Background: In this study, we investigated the potential use of keratin for oral tissue regeneration. Keratin is well-known for its effectiveness in skin regeneration by promoting keratinization and enhancing the elasticity and activity of fibroblasts. Because of its structural stability, high storability, biocompatibility, and safety in humans, existing research has predominantly focused on its role in skin wound healing. Herein, we propose using keratin proteins as biocompatible materials for dental applications. Methods: To assess the suitability of alpha-keratin protein as a substrate for cell culture, keratin was extracted from human hair via PEGylation. Viabilities of primary human gingival fibroblasts (HGFs) and human oral keratinocytes (HOKs) were assessed. Fluorescence immunostaining and migration assays were conducted using a fluorescence microscope and confocal laser scanning microscope. Wound healing and migration assays were performed using automated software to analyze the experimental readout and gap closure rate. Results: We confirmed the extraction of alpha-keratin and formation of the PEG-g-keratin complex. Treatment of HGFs with keratin protein at a concentration of 5 mg/ml promoted proliferation and maintained cell viability in the test group compared to the control group. HOKs treated with 5 mg/ml keratin exhibited a slight decrease in cell proliferation and activity after 48 hours compared to the untreated group, followed by an increase after 72 hours. Wound healing and migration assays revealed rapid closure of the area covered by HOKs over time following keratin treatment. Additionally, HOKs exhibited changes in cell morphology and increased the expression of the mesenchymal marker vimentin. Conclusion: Our study demonstrated the potential of hair keratin for soft tissue regeneration, with potential future applications in clinical settings for wound healing.

• 공업화학
• /
• 제31권6호
• /
• pp.653-659
• /
• 2020

본 연구에서는 메톡시폴리에틸렌글리콜(methoxy polyethylene glycol)과 올레아놀산(Oleanolic acid) 유도체(mPEG-OA derivative)를 합성하였으며, 합성된 유도체에 대하여 수용액에서의 용해도와 멜라닌 생성억제 효과를 평가하였다. mPEG-OA 유도체의 합성된 구조는 1H NMR, 13C NMR 및 FT-IR로 확인하였다. 수용액에서 mPEG-OA 유도체와 OA의 용해도를 측정한 결과, mPEG-OA 유도체는 13 mg/mL, OA는 0.013 mg/mL로서, mPEG-OA 유도체의 수용성이 OA보다 1,000배 높게 나타냈다. 세포생존율은 B16F10 melanoma cells에서, mPEG-OA 유도체의 세포생존율(250 μM)이 OA로 처리한 세포생존율(62.5 μM)과 비교하여 4배 증가하였다. 멜라닌 생합성 억제 효과는 세포생존율이 영향을 받지 않는 농도에서 측정하였으며, mPEG-OA 유도체는 50 μM의 농도에서 36%, OA는 10 μM의 농도에서 35%의 억제 효과를 나타내었다. B16F10 melanoma cells에서 MITF (microphthalmia-associated transcription factor)의 발현 억제 수준은 mPEG-OA 유도체는 50 μM의 농도에서 59%, OA는 10 uM의 농도에서 49%의 억제 효과를 나타내었다. 종합적으로 mPEG-OA 유도체와 OA의 수용성 및 미백활성을 비교한 결과, mPEG-OA 유도체는 OA보다 뛰어난 수용성을 가지며, 멜라닌 생합성을 억제하는 효과를 나타냄으로써 미백 기능성 화장품 소재로서 응용 가능성이 있음을 시사한다.